Study Details
A randomized, double-blind, parallel group, placebo controlled, multi-center study of solifenacin succinate 5 mg and 10 mg in patients with overactive bladder
Clinicaltrials.gov ID
N/A
Astellas Study ID
905-CL-018
EudraCT ID
N/A
Condition
Overactive Bladder Disease
Phase
Phase 3
Age
18 Years - N/A
Sex
Female & Male
Product
solifenacin succinate
Type
Interventional
Trial Dates
May 2001 - Mar 2002
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Enrollment number
907
A randomized, double-blind, parallel group, placebo controlled, multi-center study of solifenacin succinate 5 mg and 10 mg in patients with overactive bladder
Study summary
Study documents
Get More Information
Would you like more information about clinical trial sites that are recruiting participants for A randomized, double-blind, parallel group, placebo controlled, multi-center study of solifenacin succinate 5 mg and 10 mg in patients with overactive bladder? Contact us by filling our your information to the right and we’ll respond to you.